Advertisement
Advertisement
BNTX
BioNTech SE - ADR
92.80
USDSponsored
-0.87
-0.93%
Aug 10, 15:59 UTC -4
Closed
After-Market
93.10
+0.30
+0.32%
BNTX Earnings Reports
Positive Surprise Ratio
BNTX beat 18 of 28 last estimates.
64%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.13B
/$0.81
Implied change from Q2 26 (Revenue/ EPS)
+958.12%
/-136.16%
Implied change from Q3 25 (Revenue/ EPS)
-25.71%
/-775.00%
BioNTech SE - ADR earnings per share and revenue
On Aug 04, 2026, BNTX reported earnings of -2.24 USD per share (EPS) for Q2 26, missing the estimate of -2.13 USD, resulting in a -5.08% surprise. Revenue reached 106.64 million, compared to an expected 160.90 million, with a -33.72% difference. The market reacted with a -0.98% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.81 USD, with revenue projected to reach 1.13 billion USD, implying an decrease of -136.16% EPS, and increase of 958.12% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Biohaven Ltd.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.91
Surprise
-21.67%
Alamar Biosciences, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.22
Surprise
+33.83%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.55
Actual
-$0.61
Surprise
-9.83%
Enanta Pharmaceuticals, Inc
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.52
Actual
-$0.67
Surprise
-28.80%
Rocket Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.24
Actual
-$0.15
Surprise
-160.80%
Palisade Bio, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.05
Surprise
+6.19%
DiaMedica Therapeutics Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.19
Surprise
+6.86%
Orchestra BioMed Holdings, Inc. Ordinary Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.38
Surprise
+4.95%
Nkarta, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.54
Surprise
-40.81%
MAIA Biotechnology, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.13
Surprise
-15.86%
FAQ
What were BioNTech SE - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, BioNTech SE - ADR reported EPS of -$2.24, missing estimates by -5.08%, and revenue of $106.64M, -33.72% below expectations.
How did the market react to BioNTech SE - ADR's Q2 2026 earnings?
The stock price moved down -0.98%, changed from $92.25 before the earnings release to $91.35 the day after.
When is BioNTech SE - ADR expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for BioNTech SE - ADR's next earnings report?
Based on 7
analysts, BioNTech SE - ADR is expected to report EPS of $0.81 and revenue of $1.13B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement